MULTIPLEX IMMUNOHISTOCHEMISTRY IMAGE CYTOMETRY

• US 20170160171A1
• Filed: 11/18/2016
• Published: 06/08/2017
• Est. Priority Date: 11/20/2015
• Status: Abandoned Application

• Current Assignee: Oregon Health & Science University
• Original Assignee: Oregon Health & Science University
• Inventors: Tsujikawa, Takahiro, Coussens, Lisa M., Borkar, Rohan, Azimi, Vahid, Kumar, Sushil, Srinivasa, Ganapati
• Application Number:
  US15/355,933
• Publication Number:
  US 20170160171A1
• Time in Patent Office: Days
• CPC Class Codes: C12Q 1/00 Measuring or testing processes involving enzymes, nucleic acids or microorganisms measuring or testing apparatus with condition measuring or sensing means, e.g. colony counters, C12M1/34; Compositions therefor; Processes of preparing such compositions
• CPC Class Codes: G01N 1/30 Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
• CPC Class Codes: G01N 1/44 Sample treatment involving radiation, e.g. heat
• CPC Class Codes: G01N 2001/302 Stain compositions
• CPC Class Codes: G01N 2035/00138 Slides
• CPC Class Codes: G01N 2035/00356 Holding samples at elevated temperature (incubation)
• CPC Class Codes: G01N 33/6845 Methods of identifying protein-protein interactions in protein mixtures
• CPC Class Codes: G01N 35/00029 provided with flat sample substrates, e.g. slides G01N35/028 takes precedence
• CPC Class Codes: G06T 2207/10024 Color image
• CPC Class Codes: G06T 2207/10056 Microscopic image
• CPC Class Codes: G06T 2207/20132 Image cropping
• CPC Class Codes: G06T 2207/20152 Watershed segmentation
• CPC Class Codes: G06T 2207/20221 Image fusion; Image merging
• CPC Class Codes: G06T 2207/20224 Image subtraction
• CPC Class Codes: G06T 2207/30024 Cell structures in vitro; Tissue sections in vitro
• CPC Class Codes: G06T 2207/30096 Tumor; Lesion
• CPC Class Codes: G06T 5/50 using two or more images, e.g. averaging or subtraction
• CPC Class Codes: G06T 7/0012 Biomedical image inspection
• CPC Class Codes: G06T 7/0014 using an image reference approach
• CPC Class Codes: G06T 7/11 Region-based segmentation
• CPC Class Codes: G06T 7/136 : involving thresholding
• CPC Class Codes: G06T 7/337 : involving reference images or patches
• CPC Class Codes: G06T 7/90 : Determination of colour characteristics
• CPC Class Codes: G06V 10/56 : relating to colour
• CPC Class Codes: G06V 20/695 : Preprocessing, e.g. image segmentation

Abstract

Immunohistochemical (IHC) techniques that enable the sequential evaluation of at least seven biomarkers in one formalin-fixed paraffin-embedded (FFPE) tissue section are disclosed. The methods involve high-throughput multiplexed, quantitative IHC imaging, sequential IHC with iterative labeling, digital scanning, image coregistration and merging, and subsequent stripping of sections.

Claims

1. A method of performing immunohistochemistry on a formalin fixed paraffin embedded tissue section, the method comprising:

contacting the section with a first tissue antigen specific antibody that specifically binds a tissue antigen wherein the first tissue antigen specific antibody optionally comprises a first enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the first tissue antigen specific antibody if the first tissue antigen specific antibody does not comprise a first enzyme label;

contacting the section with a first colorimetric substrate of the first enzyme label, thereby visualizing one or more cells that express the first tissue antigen;

generating a first digital image of all or part of the section;

thereby completing a first staining cycle;

heating the section to at least 90°

C. for a sufficient time to remove the first tissue antigen specific antibody and the first labeled antibody from the one or more cells that express the first tissue specific antigen;

contacting the section with a second tissue antigen specific antibody that specifically binds a tissue antigen wherein the second tissue antigen specific antibody optionally comprises a second enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the second tissue antigen specific antibody if the second tissue antigen specific antibody does not comprise a second enzyme label;

contacting the section with a second colorimetric substrate of the second enzyme label, and generating a second digital image of the section, thereby completing a second staining cycle

provided that the heating is performed between the first staining cycle and the second staining cycle.

2. The method of claim 1 further comprising:

heating the section to at least 90°

C. after the second staining cycle;

contacting the section with a third tissue antigen specific antibody that specifically binds a tissue antigen wherein the third tissue antigen specific antibody optionally comprises a third enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the third tissue antigen specific antibody if the third tissue antigen specific antibody does not comprise a third enzyme label;

contacting the section with a third colorimetric substrate of the third enzyme label, and generating a third digital image of the section, thereby completing a third staining cycle;

heating the section to at least 90°

C. after the third staining cycle;

contacting the section with a fourth tissue antigen specific antibody that specifically binds a tissue antigen wherein the fourth tissue antigen specific antibody optionally comprises a fourth enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the fourth tissue antigen specific antibody if the fourth tissue antigen specific antibody does not comprise a fourth enzyme label;

contacting the section with a fourth colorimetric substrate of the fourth enzyme label, and generating a fourth digital image of the section, thereby completing a fourth staining cycle;

heating the section to at least 90°

C. after the fourth staining cycle;

contacting the section with a fifth tissue antigen specific antibody that specifically binds a tissue antigen wherein the fifth tissue antigen specific antibody optionally comprises a fifth enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the fifth tissue antigen specific antibody if the fifth tissue antigen specific antibody does not comprise a fifth enzyme label,

contacting the section with a fifth colorimetric substrate of the fifth enzyme label, and generating a fifth digital image of the section, thereby completing a fifth staining cycle;

heating the section to at least 90°

C. after the fifth staining cycle;

contacting the section with a sixth tissue antigen specific antibody that specifically binds a tissue antigen wherein the sixth tissue antigen specific antibody optionally comprises a sixth enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the sixth tissue antigen specific antibody if the sixth tissue antigen specific antibody does not comprise a sixth enzyme label;

contacting the section with a sixth colorimetric substrate of the sixth enzyme label, and generating a sixth digital image of the section, thereby completing a sixth staining cycle;

heating the section to at least 90°

C. after the sixth staining cycle;

contacting the section with a seventh tissue antigen specific antibody that specifically binds a tissue antigen wherein the seventh tissue antigen specific antibody optionally comprises a seventh enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the seventh tissue antigen specific antibody if the seventh tissue antigen specific antibody does not comprise a seventh enzyme label;

contacting the section with a seventh colorimetric substrate of the seventh enzyme label, and generating a seventh digital image of the section, thereby completing a seventh staining cycle.

3. The method of claim 2 further comprising staining the section with hematoxylin, eosin, periodic acid-Schiff'"'"'s stain, Mason'"'"'s Trichrome, Gomori Trichrome, silver salts, Wright'"'"'s, or Giemsa, thereby generating a structure-stained digital image.

4. The method of claim 3 further comprising coregistering the first, second, third, fourth, fifth, sixth and seventh digital images and merging the first, second, third, fourth, fifth, sixth, and seventh digital images into a composite image.

5. The method of claim 4 wherein coregistering the first, second, third, fourth, fifth, sixth, and seventh digital images comprises calculating a transformation that brings each of said digital images into alignment with the structure-stained digital image.

6. The method of claim 5, wherein calculating a transformation that brings each of the first, second, third, fourth, fifth, sixth, and seventh digital images digital images into alignment with the structure-stained digital image comprises calculating a delta-X and delta-Y offset among the first, second, third, fourth, fifth, sixth, and seventh digital images relative to the structure-stained digital image.

7. The method of claim 6 where coregistering the first, second, third, fourth, fifth, sixth, and seventh digital images comprises calculating a delta-X and delta-Y location among the first, second, third, fourth, fifth, sixth, and seventh digital images.

8. The method of claim 4 further comprising performing cell segmentation on the structure-stained digital image and on the first, second, third, fourth, fifth, sixth, and seventh digital images.

9. The method of claim 8 where performing cell segmentation comprises:

converting the structure-stained digital image into a grayscale structure-stained image;

inverting the pixel intensity of the grayscale structure-stained image, thereby creating an inverted grayscale structure-stained image;

differentiating the foreground and background pixels of the inverted grayscale structure-stained image using a thresholding method;

applying a watershed segmentation algorithm to the inverted grayscale structure-stained image, thereby generating a set of cell object masks;

extracting an AEC color channel from the first digital image;

overlaying the set of cell object masks on the AEC color channel, thereby creating a first masked protein stained cellular image;

measuring the intensity of one or more pixels of the first masked protein stained cellular image; and

generating a color map by assigning a number to each pixel within each cell of the first masked protein stained cellular image.

10. The method of claim 9 further comprising creating second, third, fourth, fifth, sixth, and seventh masked protein stained cellular images from the second, third, fourth, fifth, sixth and seventh digital images respectively by

extracting an AEC color channel from the second, third, fourth, fifth, sixth and seventh digital images respectively;

overlaying the set of cell object masks on the AEC color channels extracted from the AEC color channel from the second, third, fourth, fifth, sixth and seventh digital images respectively thereby creating second, third, fourth, fifth, sixth and seventh masked protein stained cellular images respectively;

measuring the intensity of one or more pixels of the second, third, fourth, fifth, sixth and seventh masked protein stained cellular images respectively; and

generating a color map by assigning a number to each pixel within each cell of the second, third, fourth, fifth, sixth and seventh masked protein stained cellular images.

11. The method of claim 4 further comprising performing tissue segmentation on the section.

12. The method of claim 11, wherein performing tissue segmentation on the section comprises defining a region of interest in the first digital image, where the region of interest comprises at least a portion of the section that includes tissue but excludes non-tissue regions;

applying an image-cleaning algorithm to the region of interest, thereby generating a cleaned region of interest;

identifying a tumor nest region within the cleaned region of interest;

applying an image cleaning algorithm to the tumor nest region, thereby generating a cleaned tumor nest region;

subtracting the cleaned tumor nest region from the cleaned region of interest, thereby generating a stromal region;

cropping the structure-stained image to fit to the cleaned tumor nest region and the stromal region; and

analyzing the cleaned tumor nest region and the stromal region by image cytometry.

13. The method of claim 1 further comprising maintaining the section at at least 90°

C. for at least 15 minutes.

14. The method of claim 1 where heating the section comprises heating the section in a microwave oven or placing the section in a heat bath.

15. The method of claim 1 where heating the section is performed in a citrate buffer of pH 5.5-6.5.

16. The method of claim 1 where the first and/or second enzyme label is selected from horseradish peroxidase, alkaline phosphatase, glucose oxidase, and β

-galactosidase.

17. The method of claim 16 where first and/or second enzyme label comprises horseradish peroxidase and the associated first and/or second colorimetric substrate comprises ABTS (2,2′

-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)), OPD (o-phenylenediamine dihydrochloride), TMB (tetramethylbenzidine), 4CN (4-chloro-1-napthol), DAB (3,3′

-diaminobenzidine), or AEC (3-amino-9-ethylcarbazole);

where the first and/or second enzyme label comprises alkaline phosphatase and the associated first and/or second colorimetric substrate comprises BCIP (5-bromo-4-chloro-3-indolyl-phosphate), and/or NBT (nitro-blue tetrazolium chloride);

where the first and/or second enzyme label comprises glucose oxidase and where the associated first and/or second colorimetric substrate comprises NBT; and

where the first and/or second enzyme label comprises β

-galactosidase and the associated first and/or second colorimetric substrate comprises X-Gal (5-bromo-4-chloro-3-indolyl-β

-D-galactopyranoside).

18. The method of claim 2 further comprising:

heating the section to at least 90°

C. after the seventh staining cycle;

contacting the section with an eighth tissue antigen specific antibody that specifically binds a tissue antigen wherein the eighth tissue antigen specific antibody optionally comprises an eighth enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the eighth tissue antigen specific antibody if the eighth tissue antigen specific antibody does not comprise an eighth enzyme label;

contacting the section with an eighth colorimetric substrate of the eighth enzyme label, and generating an eighth digital image of the section, thereby completing an eighth staining cycle;

heating the section to at least 90°

C. after the eighth staining cycle;

contacting the section with a ninth tissue antigen specific antibody that specifically binds a tissue antigen;

contacting the section with a ninth tissue antigen specific antibody that specifically binds a tissue antigen wherein the ninth tissue antigen specific antibody optionally comprises a ninth enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the ninth tissue antigen specific antibody if the ninth tissue antigen specific antibody does not comprise a ninth enzyme label;

contacting the section with a ninth colorimetric substrate of the ninth enzyme label, and generating a ninth digital image of the section, thereby completing a ninth staining cycle;

heating the section to at least 90°

C. after the ninth staining cycle;

contacting the section with a tenth tissue antigen specific antibody that specifically binds a tissue antigen wherein the tenth tissue antigen specific antibody optionally comprises a tenth enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the tenth tissue antigen specific antibody if the tenth tissue antigen specific antibody does not comprise a tenth enzyme label;

contacting the section with a tenth colorimetric substrate of the tenth enzyme label, and generating a tenth digital image of the section, thereby completing a tenth staining cycle;

heating the section to at least 90°

C. after the tenth staining cycle;

contacting the section with an eleventh tissue antigen specific antibody that specifically binds a tissue antigen wherein the eleventh tissue antigen specific antibody optionally comprises an eleventh enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the eleventh tissue antigen specific antibody if the eleventh tissue antigen specific antibody does not comprise an eleventh enzyme label;

contacting the section with an eleventh colorimetric substrate of the eleventh enzyme label, and generating an eleventh digital image of the section, thereby completing an eleventh staining cycle;

heating the section to at least 90°

C. after the eleventh staining cycle;

contacting the section with a twelfth tissue antigen specific antibody that specifically binds a tissue antigen wherein the twelfth tissue antigen specific antibody optionally comprises a twelfth enzyme label;

contacting the section with an enzyme-labeled antibody that specifically binds the twelfth tissue antigen specific antibody if the twelfth tissue antigen specific antibody does not comprise a twelfth enzyme label; and

contacting the section with a twelfth colorimetric substrate of the twelfth enzyme label, and generating a twelfth digital image of the section, thereby completing a twelfth staining cycle.

19. The method of claim 18 further comprising coregistering the eighth, ninth, tenth, eleventh, and twelfth digital images and merging the eighth, ninth, tenth, eleventh, and twelfth digital images into the composite image.

20. The method of claim 18 further comprising coregistering the eighth, ninth, tenth, eleventh, and twelfth digital images and merging the eighth, ninth, tenth, eleventh, and twelfth digital images into the composite image.

21. The method of claim 18 comprising completing 36-60 staining cycles.

22. The method of claim 18 where the first tissue specific antibody specifically binds PD-1;

the second tissue specific antibody specifically binds CD3;

the third tissue specific antibody specifically binds RORγ

T, the fourth tissue specific antibody specifically binds CD56, the fifth tissue specific antibody specifically binds CD8, the sixth tissue specific antibody specifically binds Tbet, the seventh tissue specific antibody specifically binds GATA3, the eighth tissue specific antibody specifically binds Foxp3, the ninth tissue specific antibody specifically binds PD-L1, the tenth tissue specific antibody specifically binds CD20, the eleventh tissue specific antibody specifically binds CD45, and the twelfth tissue specific antibody specifically binds EpCAM or p16.

23. The method of claim 18 where the first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth, eleventh, and twelfth enzyme labels comprise horseradish peroxidase, where the first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth, eleventh, and twelfth colorimetric substrates comprise 3-amino-9-ethylcarbazole (AEC) and where the colorimetric substrate is allowed to incubate for 20 minutes in the first staining cycle, for 20 minutes in the second staining cycle, for 10 minutes in the third staining cycle, for 40 minutes in the fourth staining cycle, for 20 minutes in the fifth staining cycle, for 20 minutes in the sixth staining cycle, for 40 minutes in the seventh staining cycle, for 20 minutes in the eighth staining cycle, for 40 minutes in the ninth staining cycle, for 20 minutes in the tenth staining cycle, for 40 minutes in the eleventh staining cycle and for 10 minutes in the twelfth staining cycle if the twelfth tissue specific antibody specifically binds EpCAM or for 20 minutes in the twelfth staining cycle if the twelfth tissue specific antibody specifically binds p16.

24. The method of claim 18 wherein the first tissue specific antibody specifically binds tryptase, the second tissue specific antibody specifically binds CD68, the third tissue specific antibody specifically binds CSF1R, the fourth tissue specific antibody specifically binds DC-SIGN, the fifth tissue specific antibody specifically binds CD66b, the sixth tissue specific antibody specifically binds CD83, the seventh tissue specific antibody specifically binds CD163, the eighth tissue specific antibody specifically binds Class II MHC, the ninth tissue specific antibody specifically binds PD-L1, the tenth tissue specific antibody specifically binds CD3, CD20, and CD56, the eleventh tissue specific antibody specifically binds CD46, and the twelfth tissue specific antibody specifically binds EpCAM or p16.

25. The method of claim 24 where the first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth, eleventh, and twelfth enzyme labels comprise horseradish peroxidase, where the first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth, eleventh, and twelfth colorimetric substrates comprise 3-amino-9-ethylcarbazole (AEC) and wherein the colorimetric substrate is allowed to incubate for 20 minutes in the first staining cycle, for 20 minutes in the second staining cycle, for 10 minutes in the third staining cycle, for 20 minutes in the fourth staining cycle, for 20 minutes in the fifth staining cycle, for 20 minutes in the sixth staining cycle, for 20 minutes in the seventh staining cycle, for 10 minutes in the eighth staining cycle, for 40 minutes in the ninth staining cycle, for 20 minutes in the tenth staining cycle, for 40 minutes in the eleventh staining cycle and for 10 minutes in the twelfth staining cycle if the twelfth tissue specific antibody specifically binds EpCAM or for 20 minutes in the twelfth staining cycle if the twelfth tissue specific antibody specifically binds p16.

26. The method of claim 1 where the first tissue antigen specific antibody and the first labeled antibody are the same antibody.

27. The method of claim 1 where the tissue section is provided on a tissue microarray.

28. The method of claim 1 further comprising destaining the colorimetric substrate.

29. The method of claim 28 where destaining the colorimetric substrate is performed using an ethanol gradient.

30. The method of claim 1 where one or more of:

contacting the section with the first tissue antigen specific antibody

contacting the section with the first labeled antibody;

contacting the section with the first colorimetric substrate;

destaining the colorimetric substrate;

or heating the section to at least 90°

C.

is performed through an automated system.

31. The method of claim 30 where the automated system performs methodology comprising automated liquid handling, movement of one or more slides to which the section is affixed via a robotic arm, or automated filling of a chamber.

32. The method of claim 1 comprising automated heating of the section to at least 95°

C.